CANAGLIFLOZIN TARGETING VASCULAR INFLAMMATION: AN OTTAWA IMAGING STUDY (CANTOR SING) - A PILOT STUDY
- Registry ID
- 20220176-01H
- Source registry
- HEALTH_CANADA
- Status
- Ongoing
- Study type
- INTERVENTIONAL
- Sponsor
- OTTAWA HEART INSTITUTE RESEARCH CORPORATION
- Start date
- 2024-10-30
- Last update
- 2023-02-13
Conditions
Related clinical trials
View on source registry